RVP
Retractable Technologies, Inc.
Medical - Instruments & Supplies
Market Cap$21M
5Y Perf.-87.2%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
RVP vs UTMD
Revenue, margins, valuation, and 5-year total return — side by side.
UTMD
Utah Medical Products, Inc.
Medical - Instruments & Supplies
Market Cap$209M
5Y Perf.-34.3%
RVP vs UTMD — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | RVP | UTMD |
|---|---|---|
| Industry | Medical - Instruments & Supplies | Medical - Instruments & Supplies |
| Market Cap | $21M | $209M |
| Revenue (TTM) | $38M | $39M |
| Net Income (TTM) | $-9M | $11M |
| Gross Margin | -6.9% | 52.9% |
| Operating Margin | -58.1% | 29.6% |
| Forward P/E | — | 10.4x |
| Total Debt | $1M | $225K |
| Cash & Equiv. | $4M | $86M |
RVP vs UTMD — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
RVP
UTMD
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Retractable Technol… (RVP) | 100 | 12.8 | -87.2% |
| Utah Medical Produc… (UTMD) | 100 | 65.7 | -34.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RVP vs UTMD
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: UTMD leads in 6 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. As sector peers, any of these can serve as alternatives in the same allocation.
RVP
Retractable Technologies, Inc.
The Lower-Volatility Pick
In this particular matchup, RVP is outpaced on most metrics by others in the set.
Best for: healthcare exposure
UTMD
Utah Medical Products, Inc.
The Income Pick
UTMD carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 3 yrs, beta 0.55, yield 1.9%
- Rev growth -5.8%, EPS growth -12.1%, 3Y rev CAGR -9.7%
- 19.0% 10Y total return vs RVP's -70.2%
Best for: income & stability and growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | UTMD | -5.8% revenue growth vs RVP's -24.2% |
| Quality / Margins | UTMD | 29.3% margin vs RVP's -22.9% |
| Stability / Safety | UTMD | Beta 0.55 vs RVP's 0.72, lower leverage |
| Dividends | UTMD | 1.9% yield, 3-year raise streak, vs RVP's 1.1% |
| Momentum (1Y) | UTMD | +23.6% vs RVP's -7.4% |
| Efficiency (ROA) | UTMD | 9.3% ROA vs RVP's -5.9%, ROIC 25.0% vs -18.4% |
RVP vs UTMD — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
Segment breakdown not available.
RVP vs UTMD — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLUTMDLAGGINGRVP
RVPRetractable Technolog…
1leads
UTMDUtah Medical Products…
5leads
6 Total Categories
CATEGORYLEADERvs RVPMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
UTMD4/6
Valuation MetricsMultiples, price ratios, and targets
RVP3/3
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
UTMD8/8
Total Returns1Y, 3Y, 5Y total returns with dividends
UTMD6/6
Risk & VolatilityBeta, volatility, and downside exposure
UTMD2/2
Analyst OutlookRatings, price targets, and dividends
UTMD2/2
Income & Cash Flow (Last 12 Months)
UTMD leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UTMD and RVP operate at a comparable scale, with $39M and $38M in trailing revenue. UTMD is the more profitable business, keeping 29.3% of every revenue dollar as net income compared to RVP's -22.9%. On growth, RVP holds the edge at +73.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | RVPRetractable Techn… | UTMDUtah Medical Prod… |
|---|---|---|
| RevenueTrailing 12 months | $38M | $39M |
| EBITDAEarnings before interest/tax | -$15M | $14M |
| Net IncomeAfter-tax profit | -$9M | $11M |
| Free Cash FlowCash after capex | -$14M | $14M |
| Gross MarginGross profit ÷ Revenue | -6.9% | +52.9% |
| Operating MarginEBIT ÷ Revenue | -58.1% | +29.6% |
| Net MarginNet income ÷ Revenue | -22.9% | +29.3% |
| FCF MarginFCF ÷ Revenue | -35.5% | +37.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +73.2% | -1.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +99.0% | -7.0% |
UTMD leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
RVP leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
| Metric | RVPRetractable Techn… | UTMDUtah Medical Prod… |
|---|---|---|
| Market CapShares × price | $21M | $209M |
| Enterprise ValueMkt cap + debt − cash | $18M | $124M |
| Trailing P/EPrice ÷ TTM EPS | -1.74x | 18.78x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 10.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 5.47x |
| EV / EBITDAEnterprise value multiple | — | 8.63x |
| Price / SalesMarket cap ÷ Revenue | 0.63x | 5.44x |
| Price / BookPrice ÷ Book value/share | 0.24x | 1.78x |
| Price / FCFMarket cap ÷ FCF | — | 14.62x |
RVP leads this category, winning 3 of 3 comparable metrics.
Profitability & Efficiency
UTMD leads this category, winning 8 of 8 comparable metrics.
Profitability & Efficiency
UTMD delivers a 9.6% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-11 for RVP. UTMD carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to RVP's 0.01x. On the Piotroski fundamental quality scale (0–9), UTMD scores 6/9 vs RVP's 4/9, reflecting solid financial health.
| Metric | RVPRetractable Techn… | UTMDUtah Medical Prod… |
|---|---|---|
| ROE (TTM)Return on equity | -11.4% | +9.6% |
| ROA (TTM)Return on assets | -5.9% | +9.3% |
| ROICReturn on invested capital | -18.4% | +25.0% |
| ROCEReturn on capital employed | -13.1% | +9.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.01x | 0.00x |
| Net DebtTotal debt minus cash | -$3M | -$86M |
| Cash & Equiv.Liquid assets | $4M | $86M |
| Total DebtShort + long-term debt | $1M | $225,000 |
| Interest CoverageEBIT ÷ Interest expense | -81.41x | — |
UTMD leads this category, winning 8 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
UTMD leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in UTMD five years ago would be worth $8,188 today (with dividends reinvested), compared to $742 for RVP. Over the past 12 months, UTMD leads with a +23.6% total return vs RVP's -7.4%. The 3-year compound annual growth rate (CAGR) favors UTMD at -9.7% vs RVP's -23.9% — a key indicator of consistent wealth creation.
| Metric | RVPRetractable Techn… | UTMDUtah Medical Prod… |
|---|---|---|
| YTD ReturnYear-to-date | -8.3% | +16.2% |
| 1-Year ReturnPast 12 months | -7.4% | +23.6% |
| 3-Year ReturnCumulative with dividends | -55.9% | -26.3% |
| 5-Year ReturnCumulative with dividends | -92.6% | -18.1% |
| 10-Year ReturnCumulative with dividends | -70.2% | +19.0% |
| CAGR (3Y)Annualised 3-year return | -23.9% | -9.7% |
UTMD leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
UTMD leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
UTMD is the less volatile stock with a 0.55 beta — it tends to amplify market swings less than RVP's 0.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UTMD currently trades 91.0% from its 52-week high vs RVP's 61.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | RVPRetractable Techn… | UTMDUtah Medical Prod… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.72x | 0.55x |
| 52-Week HighHighest price in past year | $1.14 | $71.81 |
| 52-Week LowLowest price in past year | $0.60 | $52.00 |
| % of 52W HighCurrent price vs 52-week peak | +61.1% | +91.0% |
| RSI (14)Momentum oscillator 0–100 | 57.4 | 47.3 |
| Avg Volume (50D)Average daily shares traded | 57K | 13K |
UTMD leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
UTMD leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
For income investors, UTMD offers the higher dividend yield at 1.88% vs RVP's 1.10%.
| Metric | RVPRetractable Techn… | UTMDUtah Medical Prod… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | +1.1% | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 3 |
| Dividend / ShareAnnual DPS | $0.01 | $1.23 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +4.0% |
UTMD leads this category, winning 2 of 2 comparable metrics.
Key Takeaway
UTMD leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). RVP leads in 1 (Valuation Metrics).
Best OverallUtah Medical Products, Inc. (UTMD)Leads 5 of 6 categories
Loading custom metrics...
RVP vs UTMD: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is RVP or UTMD a better buy right now?
For growth investors, Utah Medical Products, Inc.
(UTMD) is the stronger pick with -5. 8% revenue growth year-over-year, versus -24. 2% for Retractable Technologies, Inc. (RVP). Utah Medical Products, Inc. (UTMD) offers the better valuation at 18. 8x trailing P/E (10. 4x forward), making it the more compelling value choice. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — RVP or UTMD?
Over the past 5 years, Utah Medical Products, Inc.
(UTMD) delivered a total return of -18. 1%, compared to -92. 6% for Retractable Technologies, Inc. (RVP). Over 10 years, the gap is even starker: UTMD returned +19. 0% versus RVP's -70. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — RVP or UTMD?
By beta (market sensitivity over 5 years), Utah Medical Products, Inc.
(UTMD) is the lower-risk stock at 0. 55β versus Retractable Technologies, Inc. 's 0. 72β — meaning RVP is approximately 29% more volatile than UTMD relative to the S&P 500. On balance sheet safety, Utah Medical Products, Inc. (UTMD) carries a lower debt/equity ratio of 0% versus 1% for Retractable Technologies, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — RVP or UTMD?
By revenue growth (latest reported year), Utah Medical Products, Inc.
(UTMD) is pulling ahead at -5. 8% versus -24. 2% for Retractable Technologies, Inc. (RVP). On earnings-per-share growth, the picture is similar: Utah Medical Products, Inc. grew EPS -12. 1% year-over-year, compared to -66. 7% for Retractable Technologies, Inc.. Over a 3-year CAGR, UTMD leads at -9. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — RVP or UTMD?
Utah Medical Products, Inc.
(UTMD) is the more profitable company, earning 29. 3% net margin versus -36. 0% for Retractable Technologies, Inc. — meaning it keeps 29. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UTMD leads at 29. 6% versus -63. 9% for RVP. At the gross margin level — before operating expenses — UTMD leads at 51. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — RVP or UTMD?
All stocks in this comparison pay dividends.
Utah Medical Products, Inc. (UTMD) offers the highest yield at 1. 9%, versus 1. 1% for Retractable Technologies, Inc. (RVP).
07Is RVP or UTMD better for a retirement portfolio?
For long-horizon retirement investors, Utah Medical Products, Inc.
(UTMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 55), 1. 9% yield). Both have compounded well over 10 years (UTMD: +19. 0%, RVP: -70. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between RVP and UTMD?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(RVP: 73.2% · UTMD: -1.2%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.